MONTPELLIER, France, Nov. 10, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA) a company specialized in designing, developing and marketing surgical robots, announced today that it will be presenting at the upcoming Stifel 2015 Healthcare Conference in New York, NY, on Wednesday, November 18, 2015 at 4:30 pm Eastern Time. In addition to the presentation, the conference will allow Medtech to meet with U.S. investors. Bertin NAHUM, CEO and Founder of Medtech, will present on behalf of the Company, providing a company overview and update on the commercialization of the ROSA™ robotic surgery system.
The annual Stifel Healthcare Conference is a two-day event that addresses trends in biotechnology, healthcare, major and specialty pharmaceuticals, medical devices and senior housing. It provides institutional investors with access to more than 150 public and private companies and includes more than 1,000 investors and company management attendees.
Stifel Financial Corp. is a diversified financial services holding company that conducts its business through several wholly owned subsidiaries. Its primary broker-dealer subsidiary, Stifel, Nicolaus & Company, Incorporated, is a full-service brokerage and investment banking firm established in 1890.
Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.
In 2013 MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.
CONTACTS: CONTACT MEDTECH Christophe Sibillin Chief Financial Officer Tel : +33 (0)4 67 10 77 40 INVESTORS Corinne Puissant Tel : +33 (0)1 53 67 36 77 firstname.lastname@example.org PRESS Alexandra Prisa (EU) Tel. : +33(0)1 53 67 36 90 email@example.com Joanna Zimmerman (US) Tel : +1 646-536-7006 firstname.lastname@example.org